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urine drug screen, an acetaminophen level, a salicylate level,
a serum ethanol level, and serum and urine osmolalities were
obtained. These laboratories were remarkable for benzodiazapines
in the patient’s urine and a serum osmolality of 394mOsmol/kg,
resulting in an osmolar gap of 89.1mOsmol/kg.

CHF patients commonly experience muscle weakness and
fatigue as two major symptoms. An altered intracellular
handling of ionized calcium has been suggested to play a vital
role in impaired myocardial contraction.3 In isolated myocytes
from patients with end stage heart failure, systolic ionized
calcium levels were markedly decreased, while diastolic levels
were elevated as compared to healthy controls. 4 In addition,
digitalis and beta-blocker medical therapy is frequently used
in CHF patients and is known to increase myocardial ionized
calcium levels.5

At this point, the differential diagnosis included ethylene glycol,
isopropyl alcohol, or methanol toxicity and laboratories for these
toxins were sent. Poison control was contacted and the patient
was started on fomepizole infusion at 15mg/kg. The patient’s
clinical condition continued to deteriorate. Her acidosis and
acute renal failure worsened, necessitating the initiation of
continuous venovenous hemodialysis. The patient remained
unresponsive, and neurology consultation deemed that her
prognosis was extremely poor.

Congestive heart failure (CHF) is a chronic medical condition whose
incidence is rising. The prevalence of CHF is approximately 1% to
3% in Western countries.1 Despite innovations in medical therapy,
CHF is associated with high morbidity and mortality rates.2

The patient’s past medical history was notable for fibromyalgia
and migraine headaches, and her past surgical history included
a tonsillectomy. Her past psychiatric history was significant for
depression and a prior suicide attempt, involving wrist slitting.
The patient had no known drug allergies and her medications
included valium, topamax, oxycontin, percocet and lunesta as
needed. She did not take any over the counter medications or
herbal supplements. The patient consumed alcohol occasionally
and smoked cigarettes, but did not use any illicit drugs. Her
family history was unremarkable.
Upon admission, the patient’s vital signs were notable for a
temperature of 102°F and a heart rate of 140 beats per minute.
Physical exam revealed dry mucous membranes and tachycardia.
On neurologic exam, the patient was found to be unresponsive to
all stimuli, including sternal rub. Neurologic exam was remarkable
for a left pupil that was sluggishly reactive to light, a right pupil
that was midposition and fixed, and the absence of a gag reflex
and corneal reflexes. Routine laboratories were notable for a white
blood cell count of 31B/L, hemoglobin 17.6g/dL, serum sodium
150mmol/L, serum chloride 118mmol/L, bicarbonate 5mmol/L,
creatinine 1.6mg/dL, and an anion gap of 31mmol/dL. Also of
note, an arterial blood gas performed at the time of presentation
showed a pH of 6.76, PCO2 32mmHg, PO2 345mmHg,
bicarbonate 4mmol/L, and an oxygen saturation of 99% on 100%
FIO2. A CAT scan of the head at the time of admission showed
diffuse cerebral edema with no infarct identified.

Hospital Course

This critically ill patient with a severe metabolic acidosis was
admitted to the intensive care unit. She was aggressively hydrated
and started on a bicarbonate infusion for treatment of her acidosis.
She was also given a dose of mannitol to reduce the risk of cerebral
herniation in light of her diffuse cerebral edema. Additionally, she
was started empirically on broad spectrum antibiotics. As there
was a concern for a possible suicide attempt via an overdose, a

On the second day of hospitalization, the patient’s metabolic
disturbances continued to worsen, and she developed lactic
acidosis with rhabdomyolysis. Her ethylene glycol level came
back elevated at 39mg/dL. Since all other avenues of treatment
had been exhausted and patient’s clinical status was continuing
to decline, Thomas Jefferson University Hospital’s hypothermia
protocol was initiated.
After 24 hours, patient was rewarmed and her electrolyte
disturbances and acidosis began to resolve. The patient, however,
remained unresponsive. On the forth day of hospitalization, the
patient’s neurologic status began to improve, as she was able to
open her eyes and move her extremities. At this point, she was
noted to have right sided weakness so a CAT scan of her head
was repeated, which showed a new left occipital lobe infarction
and slightly decreased cerebral edema.
On the sixth day of hospitalization, the patient began following
commands and was extubated. At this point, her mental status was
completely back to baseline and she had no neurologic deficits.
Her renal function remained poor and she was continued on
hemodialysis. The patient was transferred to inpatient psychiatry
on day 10 of her hospitalization. While on the inpatient psychiatry
floor, her renal function improved and dialysis was discontinued.
She was discharged home from inpatient psychiatry after 12 days,
with no residual neurological symptoms.

Discussion

Although not a significant cause of mortality in the US, ethylene
glycol consumption is responsible for dozens of fatal intoxications
annually. It is a major constituent of antifreeze, de-icing solutions,
windshield wiper fluid, solvents, cleaners, and fuels. Typically
consumption is due to suicide attempt but can also be secondary
to ethanol substitution or accidental consumption. Significant
toxicity can be seen with consumption of small amounts, and
toxic levels of 1g/kg are considered lethal. 1,2
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Ethylene glycol is metabolized by alcohol dehydrogenase and
aldehyde dehydrogenase. The parent molecule itself is nontoxic,
but is noted to cause CNS depression. Its metabolites, primarily
glycolate, glyoxylate and oxalate are responsible for the toxic
effects of ethylene glycol. Upon consumption, ethylene glycol is
rapidly absorbed by the stomach and small intestine, achieving
peak concentrations within one to two hours. The half-life of
ethylene glycol ranges from 3 to 9 hours or longer if alcohol
dehydrogenase is inhibited.3

improved survival in the group receiving hypothermic cooling.5
Similar findings were noted in the Hypothermia After Cardiac
Arrest Study Group as well. 6 A study using animal models
elucidated mechanisms by which hypothermia may be
neuroprotective including: decreased excitotoxic neurotransmitters, diminished oxidative stress, suppressed cerebral
edema preserving blood brain barrier, decreased post-ischemic
inflammation, normalized acid-base status in brain, and
restoration of protein synthesis.7

Typically, the progression of symptoms from ethylene glycol
consumption includes initial CNS symptoms, followed
by cardiopulmonary manifestations, and ultimately renal
involvement. The presentation can be largely variable depending
on the amount ingested, the degree of metabolism, and the
presence of ethanol co-ingestion. A wide spectrum of systemic
effects can occur. In addition, in the preterminal stage of the
illness, cerebral herniation and multi-system organ failure are
often present.1,2

At Thomas Jefferson University Hospital, the hypothermia
protocol was adopted for use with patients status post cardiac
arrest. However, given this patient’s neurological presentation,
the protocol was instituted for neuroprotective purposes. In
addition, intoxication due to ethylene glycol was the cause of
her neurological dysfunction and also a contraindication to
the use of hypothermic cooling per the institution’s protocol.
However, in our patient’s case there were several mitigating
circumstances: the threat of herniation, inability to use mannitol
due to her elevated serum osmolality, and her young age that
warranted the use of hypothermic cooling.

Blood work typically reveals a profoundly elevated anion gap
metabolic acidosis with a lactate level insufficient to account for
the degree of acidosis. Also, the patient can have an elevated
plasma osmolar gap. However, no single laboratory study, with
the exception of an elevated serum ethylene glycol level, is
definitively diagnostic for ethylene glycol poisoning. A serum
osmolar gap is present in a variety of intoxications including
ethanol, isopropyl alcohol, and methanol toxicity.1,3
A high clinical suspicion for intoxication and early treatment
are essential for the successful management of a patient with
ethylene glycol ingestion. The core components of managing
ethylene glycol toxicity include maintenance of cardiopulmonary function as well as the use of the alcohol dehydrogenase
antagonist fomepizole, sodium bicarbonate infusion,
hemodialysis, and consultation with medical toxicology and
poison control.1
Generally, the use of intravenous sodium bicarbonate is
recommended for metabolic acidosis with a pH less that 7.3.
Infusions have been shown to increase excretion of active
metabolites, as well as decrease end organ damage. Fomepizole
is an antidote for methanol and ethylene glycol poisoning that
acts as a competitive antagonist of alcohol dehydrogenase.
It has a binding affinity of greater than 8,000 times ethanol
and has efficacy that may obviate the need for hemodialysis.
Hemodialysis rapidly removes toxic metabolites and is mostly
indicated for use in patients with acute renal failure, as renal
function may take days to months to recover.4 The hypothermia
protocol utilized in our patient has no evidence-based support
for treatment of ethylene glycol associated cerebral edema. Its
established use has been in patients who are status post cardiac
arrest to preserve neurological function in the setting of cerebral
hypoperfusion. Bernard et al. conducted a study of 77 subjects
randomized to normothermic and hypothermic treatment after
ventricular fibrillation arrest and resuscitation with a significant
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